Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Afd Pharmacoepi & Clinical Pharmacology"'
Autor:
Sallevelt, Bastiaan T.G.M., Egberts, Toine C.G., Huibers, Corlina J.A., Ietswaart, Jimmy, Drenth-van Maanen, A. Clara, Jennings, Emma, O’Mahony, Cian, Jungo, Katharina Tabea, Feller, Martin, Rodondi, Nicolas, Sibille, François Xavier, Spinewine, Anne, van Puijenbroek, Eugène P., Wilting, Ingeborg, Knol, Wilma, Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
Publikováno v:
Sallevelt, Bastiaan T G M; Egberts, Toine C G; Huibers, Corlina J A; Ietswaart, Jimmy; Drenth-van Maanen, A Clara; Jennings, Emma; O'Mahony, Cian; Jungo, Katharina Tabea; Feller, Martin; Rodondi, Nicolas; Sibille, François-Xavier; Spinewine, Anne; van Puijenbroek, Eugène P; Wilting, Ingeborg; Knol, Wilma (2022). Detectability of Medication Errors With a STOPP/START-Based Medication Review in Older People Prior to a Potentially Preventable Drug-Related Hospital Admission. Drug safety, 45(12), pp. 1501-1516. Springer 10.1007/s40264-022-01237-5
Drug Safety, Vol. 45, no. 12, p. 1501-1516 (2022)
Drug Safety, 45(12), 1501-1516. ADIS INT LTD
Drug Safety, 45(12), 1501. Springer International Publishing Switzerland
Drug Safety, Vol. 45, no. 12, p. 1501-1516 (2022)
Drug Safety, 45(12), 1501-1516. ADIS INT LTD
Drug Safety, 45(12), 1501. Springer International Publishing Switzerland
Introduction: Multimorbidity and polypharmacy are risk factors for drug-related hospital admissions (DRAs) in the ageing population. DRAs caused by medication errors (MEs) are considered potentially preventable. The STOPP/START criteria were develope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::672f3898b660657eeff946433fea2c39
https://boris.unibe.ch/174450/8/Sallevelt_DrugSaf_2022.pdf
https://boris.unibe.ch/174450/8/Sallevelt_DrugSaf_2022.pdf
Autor:
Emilie M Gieling, Anthonius de Boer, Rachel G. Williams, Hein A W van Onzenoort, Cornelis Kramers, Vincent ten Cate, Andrea M. Burden, Frank de Vries
Publikováno v:
International Journal of Clinical Pharmacy, 41 (6)
International Journal of Clinical Pharmacy, 41, 1536-1544
International Journal of Clinical Pharmacy, 41, 6, pp. 1536-1544
International Journal of Clinical Pharmacy, 2019(41). Springer
International Journal of Clinical Pharmacy, 41(6), 1536. Springer Netherlands
International Journal of Clinical Pharmacy, 41(6), 1536-1544. Springer, Cham
International Journal of Clinical Pharmacy, 41, 1536-1544
International Journal of Clinical Pharmacy, 41, 6, pp. 1536-1544
International Journal of Clinical Pharmacy, 2019(41). Springer
International Journal of Clinical Pharmacy, 41(6), 1536. Springer Netherlands
International Journal of Clinical Pharmacy, 41(6), 1536-1544. Springer, Cham
Background As an alternative to vitamin K antagonist and low-dose aspirin ( 2). Conclusion Non vitamin K oral anticoagulants are associated with a higher risk on all-cause mortality, particularly in men and in patients with higher stroke risk.
I
I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::932f5765f851dba8d5d2c8ab70671a41
https://hdl.handle.net/20.500.11850/385382
https://hdl.handle.net/20.500.11850/385382